Trial intelligence / Profile preview

Elemental vs. Semi-solid Diets for Reflux in Bedridden PEG Patients

NCT02290626Withdrawn

Sponsor
Showa Inan General Hospital
Start
Nov 2014
Primary completion
Mar 2016
Countries
1
01

Overview

Randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Showa Inan General Hospital. Primary endpoint: Gastroesophageal regurgitation at 1 hour. Planned start Nov 2014; status: withdrawn.

02

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT02290626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02290626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call